It’s a year ago this Friday since LC said” we should have a Hervaxx update within 3 to 6 months. The longer you wait the better the results will be”
The news we have been waiting for all this time is coming . And it’s going to be very good.
It looks like we will get early efficacy news for both PD1Vax and CF33 next year.
Leslies comment about designing the trials to get very early signals of efficacy is a real bonus. It certainly appears they want to be well and truly on the radar before long.
It makes a lot of sense to partner early with both HerVAX and CF33 having over 60 different cancers to target. That’s more than 120 target cancers.
That’s a lot of trials to run and a lot of co-therapies that big pharma will want to match up with their current therapies..
This is coming together much sooner than expected. The timelines discussed here from the clinical trials site are not going to weigh IMU down .
Shareprice will reflect the asset value much earlier than those timelines suggest.
- Forums
- ASX - By Stock
- IMU
- Media Thread
Media Thread, page-29
-
-
- There are more pages in this discussion • 14,343 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
(20min delay)
|
|||||
Last
5.7¢ |
Change
0.003(5.56%) |
Mkt cap ! $417.2M |
Open | High | Low | Value | Volume |
5.5¢ | 5.8¢ | 5.2¢ | $2.499M | 45.00M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 1921794 | 5.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.7¢ | 1368288 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 1921794 | 0.056 |
5 | 286362 | 0.055 |
12 | 3517552 | 0.054 |
17 | 2756044 | 0.053 |
23 | 2021898 | 0.052 |
Price($) | Vol. | No. |
---|---|---|
0.057 | 1368288 | 7 |
0.058 | 2564048 | 15 |
0.059 | 3137099 | 10 |
0.060 | 2176188 | 16 |
0.061 | 1460386 | 7 |
Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online